Tag: Evelina London Children’s Hospital

Palforzia

Palforzia Shows Positive Results in Peanut-Allergic Children Ages 1-3 in Phase...

73.5% of patients treated with PALFORZIA tolerated a 600 mg single dose of peanut protein at 12 months.
Palforzia Capsules with Logo

Positive Results from Phase 3 Study of PALFORZIA® in Peanut-Allergic Children...

73.5% of patients treated met the primary outcome at 12 months compared with 6.3% of patients in the placebo arm.